We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
Cap. Flow
-$439M
Cap. Flow %
-15.9%
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$17.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$17.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14M
5
CUTR
Cutera, Inc.
CUTR
+$12.7M

Top Sells

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$24.7M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.4M
3
LIVN icon
LivaNova
LIVN
+$20.2M
4
GKOS icon
Glaukos
GKOS
+$17.5M
5
COO icon
Cooper Companies
COO
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.75%
2 Consumer Staples 0.58%
3 Financials 0.5%
4 Consumer Discretionary 0.42%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
76
10x Genomics
TXG
$7.52B
$9.23M 0.33%
61,957
-1,704
-3% -$261K
ARNA
77
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$9.02M 0.33%
97,100
-2,900
-3% -$191K
PFE icon
78
Pfizer
PFE
$150B
$8.99M 0.33%
+152,273
New +$7.54M
IDXX icon
79
PUT
Idexx Laboratories
IDXX
$45B
$8.63M 0.31%
13,100
-16,900
-56% -$10.6M
LNTH icon
80
Lantheus
LNTH
$6.57B
$8.54M 0.31%
295,695
-41,231
-12% -$1.1M
TRUP icon
81
PUT
Trupanion
TRUP
$1.33B
$8.5M 0.31%
64,400
-123,800
-66% -$14.4M
TFX icon
82
PUT
Teleflex
TFX
$6.03B
$8.47M 0.31%
25,800
+5,800
+29% +$1.97M
IART icon
83
PUT
Integra LifeSciences
IART
$1.35B
$8.25M 0.3%
123,200
-121,900
-50% -$8.25M
MASS icon
84
908 Devices
MASS
$414M
$8.1M 0.29%
312,946
+132,058
+73% +$3.88M
MEDP icon
85
PUT
Medpace
MEDP
$16.7B
$8.01M 0.29%
36,800
-500
-1% -$105K
BVS icon
86
Bioventus
BVS
$1.17B
$8M 0.29%
552,210
+123,081
+29% +$1.75M
DAL icon
87
PUT
Delta Air Lines
DAL
$59.1B
$7.7M 0.28%
+197,100
New +$7.89M
OSH
88
PUT
DELISTED
Oak Street Health, Inc.
OSH
$7.67M 0.28%
+231,600
New +$8.76M
OLK
89
CALL
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$7.47M 0.27%
+410,400
New +$10.1M
OHI icon
90
PUT
Omega Healthcare
OHI
$13.9B
$7.29M 0.26%
+246,400
New +$7.19M
TELA icon
91
TELA Bio
TELA
$32.3M
$7.22M 0.26%
564,120
-16,395
-3% -$208K
ISRG icon
92
PUT
Intuitive Surgical
ISRG
$142B
$7.19M 0.26%
+20,000
New +$6.88M
NKTR icon
93
CALL
Nektar Therapeutics
NKTR
$2.57B
$7.09M 0.26%
34,987
+12,480
+55% +$2.71M
SGFY
94
PUT
DELISTED
Signify Health, Inc.
SGFY
$7.06M 0.26%
+496,700
New +$7.69M
NVCR icon
95
PUT
NovoCure
NVCR
$2.05B
$7.04M 0.26%
93,800
+29,700
+46% +$2.98M
CTKB icon
96
Cytek Biosciences
CTKB
$621M
$6.88M 0.25%
421,777
-22,591
-5% -$473K
PACB icon
97
Pacific Biosciences
PACB
$345M
$6.75M 0.24%
330,033
-10,110
-3% -$244K
VRAY
98
CALL
DELISTED
ViewRay, Inc.
VRAY
$6.52M 0.24%
1,182,800
+682,800
+137% +$4.16M
NTLA icon
99
Intellia Therapeutics
NTLA
$1.69B
$6.38M 0.23%
53,929
+11,870
+28% +$1.49M
AGL icon
100
Agilon Health
AGL
$1.45B
$6.24M 0.23%
9,248
-8,648
-48% -$5.26M
2 3
4
5 6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.

  • Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
  • Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
  • Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
  • Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
  • Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.